Poster Abstract Session:
110. Antimicrobials: Resistance Mechanisms
Friday, October 4, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: Adult ID, Epidemiology and Infection Control


Linezolid Experience and Accurate Determination of Resistance (LEADER) Program for 2012: Regional Activity of Linezolid and Comparator Compounds
Jennifer Streit ; James Ross ; Rodrigo Mendes ; Robert Flamm ; Ronald Jones, MD ; Patricia Hogan
  • IDWEEK 2013 LEADER 737.pdf (115.9 kB)

  • 738
    Activity of Fosfomycin Against Carbapenem Resistant Enterobacteriaceae
    Tiffany R. Keepers, PhD ; Chris Celeri ; Marcela Gomez ; Donald Biek, PhD ; Rolf Wagenaar ; Ian A. Critchley, PhD

    Multidrug Resistant Pseudomonas aeruginosa (MDR-Pa) causing prosthetic valve endocarditis (PVE): a link between resistance and virulence
    T. Nicholas Domitrovic, BA ; Andrea M. Hujer, BS ; Federico Perez, MD ; Steve Marshall, MS ; Kristine M. Hujer, BS ; Laila Woc-Coburn, M.D., D.T.M.&H. ; Mark Parta, MD ; Robert A. Bonomo, MD

    Emerging NDM-1 ‚-Lactamase-Producing† Enterobacteriaceae in Kuwait
    Vincent Rotimi, MD, PhD ; Wafaa Jamal, MD, PhD ; John Albert, PhD ; Fatima Khodakhast, BSc ; Laurent Poirel, PhD

    Protective Effects of Pyridoxine Against Side-Effects Induced by Linezolid
    Metehan Ozen, Professor ; Yasemin Kendir, MD ; Efkan Uz ; Ramazan Yilmaz ; Ali Ayata

    Low dose nitric oxide as adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Katrina Cathie, BM (Hons), MRCPCH ; Robert Howlin, PhD ; Priya Sukhtankar, MRCPCH ; Caroline Duignan, MSc ; Sandra Pink, BA ; Caroline Smith, RN ; Johanna Jefferies, PhD, MFPH ; Rami Salib, PhD FRCS(ORL-HNS) ; Mary Carroll, MD FRCP ; Julian Legg, MD FRCPCH ; Thomas Daniels, MRCP DM ; Gary Connett, MD FRCPCH ; Nicolas Barraud, PhD ; Scott Rice, PhD ; Michael Kelso, PhD ; Staffan Kjelleberg, PhD ; Paul Stoodley, PhD ; Luanne Hall-Stoodley, PhD ; Stuart Clarke, PhD FFPH FRCPath ; Jeremy Webb, PhD ; Saul Faust, MBBS MRCPCH PhD

    Variability of Resistance Rates among Streptococcus spp. Isolated from Different Regions and Sources of Infection (TEST 2008-2012)
    Douglas Biedenbach, BS ; Stephen Hawser, PhD ; Meredith Hackel, PhD ; Samuel Bouchillon, MD ; Daryl Hoban, PhD ; Robert Badal, BS ; Heidi Leister-Tebbe, BS
  • IDSA 743.pdf (608.7 kB)

  • 745
    Comparative Analysis of Multi-Beta-Lactam Resistant and KPC-positive K. pneumoniae and E. coli Clinical Isolates in Puerto Rico for 2009 and 2012
    Teresa Martinez, PhDc ; Guillermo J Vazquez, MD ; Edna E Aquino, MT, PhD ; Jorge L Santana, MD, FIDSA ; Maria I Sante, MD ; Iraida E Robledo, MS, PhD

    KPC Conjugation into Virulent Klebsiella pneumoniae
    Catherine Koper, MD ; Robert Eng, MD ; Tom Chiang, MD ; Kris Siu, PhD
  • IDSA_poster746_Koper.pdf (476.4 kB)

  • 748
    Advancing Antimicrobial Resistance Surveillance: An Empirical Approach to Deriving a Composite Drug Resistance Index for Urinary Tract Infections
    David M. Patrick, MD, MHSc, FRCPC ; Catharine Chambers, MSc ; Mei Chong, MSc ; Dale Purych, MD ; Fawziah Marra, PharmD

    Whole Genome Sequencing of Linezolid Resistant Coagulase Negative Staphylococci reveals limited genomic mutations associated with resistance
    Theodoros Kelesidis, MD ; Bing Gu, MD ; Ryan Tewhey, PhD ; Carmen L. Giltner, PhD. ; April M. Bobenchik, PhD. ; Janet A. Hindler, MCLS, MT ; Romney M. Humphries, Ph.D.

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.